Search Results

PRONAI SECURES $12 MILLION SERIES C FINANCING.

Subjects: *WOMEN chief executive officers; FINANCE of pharmaceutical research; DRUG developmentPRONAI Therapeutics Inc.SOOCH, Mina

• Source: Biotech Business. Feb2014, Vol. 27 Issue 2, p5-6. 2p.

Record details

Turkey Increases R&D Incentives.

• Authors : Atilgan-Karakuiak, Özge¹; Geçgil, Tugçe Avcisert²

Subjects: *FOREIGN investments; *RESEARCH & development projects; *RESEARCH institutesTURKEY

• Source: Pharmaceutical Technology Europe. Feb2014, Vol. 26 Issue 2, p12-14. 2p.

Record details

Orphan Drugs: Rare Diseases, Rare Funding.

• Authors : Burdg, Jessica

Subjects: FINANCE of pharmaceutical research; TREATMENT of rare diseases; DRUG efficacy

• Source: Laboratory Equipment. Sep2015, Vol. 52 Issue 5, p24-25. 2p.

Record details

Balms for the poor.

Subjects: *PHARMACEUTICAL industry; FINANCE of pharmaceutical research; TROPICAL medicine

• Source: Economist. 8/14/1999, Vol. 352 Issue 8132, p63-65. 3p. 1 Graph.

Record details

Arbor Pharmaceuticals Inc.

Subjects: *INVESTORS; *PHARMACEUTICAL industry; FINANCE of pharmaceutical researchARBOR Pharmaceuticals (Company) ; ACCENTIA BioPharmaceuticals Inc. ACCENTIA BioPharmaceuticals Inc. ACCENTIA BioPharmaceuticals Inc. ABPI

• Source: START -- UP. Jan2009, Vol. 14 Issue 1, p50-51. 2p.

Record details

Atlas neurological upstart Disarm gains $30M, AbbVie backing.

• Authors : Adams, Ben

Subjects: *BIOTECHNOLOGY; *FINANCE; DRUG development

• Source: FierceBiotech. 9/19/2017, p1-1. 1p.

Record details

SYNCHRONEURON RAISES $20 MILLION IN SERIES B.

Subjects: *INVESTMENTS; FINANCE of pharmaceutical research; ACAMPROSATE calciumSYNCHRONEURON Inc. ; MORNINGSIDE Technology Ventures Ltd.CHAN, Gerald

• Source: Biotech Financial Reports. Aug2014, Vol. 21 Issue 8, p4-6. 3p.

Record details

All together now.

Subjects: *FINANCING of charities; *FINANCING of new business enterprises; *BUSINESS planning

• Source: Economist. 4/21/2012, Vol. 403 Issue 8781, p79-79. 1/2p.

Record details

START-UP PREVIEWS.

Subjects: *NEW business enterprises; FINANCE of pharmaceutical research; DRUG developmentTHIRD Rock (Company) ; EMBER Therapeutics (Company) ; THERMALIN Diabetes Inc.

• Source: IN VIVO. Feb2012, Vol. 30 Issue 2, p65-65. 1p.

Record details

EIB PLANS TO LEND GRUPO FERRER €50M.

Subjects: FINANCE of pharmaceutical researchEUROPEAN Investment Bank ; GRUPO Ferrer Internacional SA

• Source: Manufacturing Chemist. Nov2014, Vol. 85 Issue 11, p8-8. 1/8p.

Record details